Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience

Systemic sclerosis (SSc) is a chronic autoimmune disorder characterized by multisystem involvement. Patients can be stratified into an indolent or rapidly progressive disease course. A progressive course warrants early and more aggressive treatment to prevent irreversible organ damage. Therapeutic...

Full description

Saved in:
Bibliographic Details
Main Authors: Marko Barešić, Ljiljana Smiljanić Tomičević, Igor Aurer, Mislav Cerovec, Branimir Anić
Format: Article
Language:English
Published: PAGEPress Publications 2025-05-01
Series:Reumatismo
Subjects:
Online Access:https://www.reumatismo.org/reuma/article/view/1822
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850105615864561664
author Marko Barešić
Ljiljana Smiljanić Tomičević
Igor Aurer
Mislav Cerovec
Branimir Anić
author_facet Marko Barešić
Ljiljana Smiljanić Tomičević
Igor Aurer
Mislav Cerovec
Branimir Anić
author_sort Marko Barešić
collection DOAJ
description Systemic sclerosis (SSc) is a chronic autoimmune disorder characterized by multisystem involvement. Patients can be stratified into an indolent or rapidly progressive disease course. A progressive course warrants early and more aggressive treatment to prevent irreversible organ damage. Therapeutic strategies should be tailored to the presenting symptoms and organ involvement. Autologous hematopoietic stem cell transplantation (AHSCT) has proven to be an effective treatment modality for specific phenotypes of SSc, especially progressive diffuse cutaneous SSc. However, the optimal timing for the transplantation remains unknown. We present two cases of rapidly progressive diffuse cutaneous systemic sclerosis (dcSSc) treated with AHSCT following inadequate response to conventional immunosuppressive therapy. While both patients experienced significant cutaneous improvement post-AHSCT, internal organ involvement progressed in one case, ultimately resulting in a fatal outcome due to severe sepsis, whereas the second patient remained clinically stable and without immunosuppressive therapy during long-term follow-up. This report contributes to the growing body of evidence supporting AHSCT as a therapeutic option in carefully selected cases of progressive dcSSc. To our knowledge, our cases are the first successful experiences with this treatment modality in Croatia and among the Slavic populations of the Balkan Peninsula, promoting the need for earlier interventions in patients who develop a progressive disease course, particularly with skin involvement.
format Article
id doaj-art-0c39cf49bc3b475b8f4eebac4eec6ef6
institution OA Journals
issn 0048-7449
2240-2683
language English
publishDate 2025-05-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj-art-0c39cf49bc3b475b8f4eebac4eec6ef62025-08-20T02:39:02ZengPAGEPress PublicationsReumatismo0048-74492240-26832025-05-0110.4081/reumatismo.2025.1822Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experienceMarko Barešić0Ljiljana Smiljanić Tomičević1https://orcid.org/0000-0003-2807-7440Igor Aurer2Mislav Cerovec3Branimir Anić4Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of ZagrebDivision of Clinical Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of ZagrebDivision of Hematology, Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of ZagrebDivision of Clinical Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of ZagrebDivision of Clinical Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of Zagreb Systemic sclerosis (SSc) is a chronic autoimmune disorder characterized by multisystem involvement. Patients can be stratified into an indolent or rapidly progressive disease course. A progressive course warrants early and more aggressive treatment to prevent irreversible organ damage. Therapeutic strategies should be tailored to the presenting symptoms and organ involvement. Autologous hematopoietic stem cell transplantation (AHSCT) has proven to be an effective treatment modality for specific phenotypes of SSc, especially progressive diffuse cutaneous SSc. However, the optimal timing for the transplantation remains unknown. We present two cases of rapidly progressive diffuse cutaneous systemic sclerosis (dcSSc) treated with AHSCT following inadequate response to conventional immunosuppressive therapy. While both patients experienced significant cutaneous improvement post-AHSCT, internal organ involvement progressed in one case, ultimately resulting in a fatal outcome due to severe sepsis, whereas the second patient remained clinically stable and without immunosuppressive therapy during long-term follow-up. This report contributes to the growing body of evidence supporting AHSCT as a therapeutic option in carefully selected cases of progressive dcSSc. To our knowledge, our cases are the first successful experiences with this treatment modality in Croatia and among the Slavic populations of the Balkan Peninsula, promoting the need for earlier interventions in patients who develop a progressive disease course, particularly with skin involvement. https://www.reumatismo.org/reuma/article/view/1822Systemic sclerosisautologous stem cell transplantationmodified Rodnan skin scoreCroatia
spellingShingle Marko Barešić
Ljiljana Smiljanić Tomičević
Igor Aurer
Mislav Cerovec
Branimir Anić
Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience
Reumatismo
Systemic sclerosis
autologous stem cell transplantation
modified Rodnan skin score
Croatia
title Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience
title_full Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience
title_fullStr Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience
title_full_unstemmed Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience
title_short Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience
title_sort autologous hematopoietic stem cell transplantation in diffuse cutaneous systemic sclerosis a single center experience
topic Systemic sclerosis
autologous stem cell transplantation
modified Rodnan skin score
Croatia
url https://www.reumatismo.org/reuma/article/view/1822
work_keys_str_mv AT markobaresic autologoushematopoieticstemcelltransplantationindiffusecutaneoussystemicsclerosisasinglecenterexperience
AT ljiljanasmiljanictomicevic autologoushematopoieticstemcelltransplantationindiffusecutaneoussystemicsclerosisasinglecenterexperience
AT igoraurer autologoushematopoieticstemcelltransplantationindiffusecutaneoussystemicsclerosisasinglecenterexperience
AT mislavcerovec autologoushematopoieticstemcelltransplantationindiffusecutaneoussystemicsclerosisasinglecenterexperience
AT branimiranic autologoushematopoieticstemcelltransplantationindiffusecutaneoussystemicsclerosisasinglecenterexperience